| 000 | 01719 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250512033906.0 | ||
| 264 | 0 | _c19860724 | |
| 008 | 198607s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/17.suppl_b.93 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDellamonica, P | |
| 245 | 0 | 0 |
_aThe diffusion of pefloxacin into bone and the treatment of osteomyelitis. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cApr 1986 |
||
| 300 |
_a93-102 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xblood |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aBone and Bones _xanalysis |
| 650 | 0 | 4 |
_aCalcium _xanalysis |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDiffusion |
| 650 | 0 | 4 |
_aEnterococcus faecalis _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorine _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorfloxacin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aOsteomyelitis _xdrug therapy |
| 650 | 0 | 4 | _aPefloxacin |
| 650 | 0 | 4 |
_aPhosphorus _xanalysis |
| 650 | 0 | 4 |
_aProteus mirabilis _xdrug effects |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 |
_aSerratia marcescens _xdrug effects |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aBernard, E | |
| 700 | 1 | _aEtesse, H | |
| 700 | 1 | _aGarraffo, R | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 17 Suppl B _gp. 93-102 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/17.suppl_b.93 _zAvailable from publisher's website |
| 999 |
_c3092083 _d3092083 |
||